A solid position in a growing market
Arseus is a R&D scientific company delivering innovative solutions and concepts to professionals and institutions in the healthcare sector in 30 countries worldwide. Arseus is subdivided into three divisions: Fagron is global market leader in pharmaceutical compounding. Corilus develops and supplies unique integrated ICT solutions with substantial added value to medical specialists and is market leader in Belgium, France and the Netherlands. HL Technology develops and produces innovative healthcare devices for the dental and medical markets. The Belgian company Arseus NV is located in Waregem, and is listed on NYSE Euronext Brussels and NYSE Euronext Amsterdam. The operational activities of the Arseus group are driven by the Dutch company Arseus BV. The head office of Arseus BV is located in Rotterdam.
Our service-oriented organisation offers innovative and tailored products and solutions to our customers. Arseus aims to capture a leading position in every market or product segment in which it operates.
With strong home brands, exclusive distribution agreements and high added value, Arseus is capable of distinguishing itself from the competition. As a Group, we are better able to use our knowledge, our consumer insight and our economies of scale to arrive at simple, sound and efficient ways of working.
The more than 2,000 employees of Arseus work in close cooperation and actively exchange knowledge and expertise with one another. This allows Arseus to respond quickly, creatively and accurately to changing customer wishes and developments on the markets.
Arseus wishes to realise sustainable growth by retaining its
leading position in selected segments of the professional
healthcare sector and to expand through organic growth and an
active buy-and-build strategy.